Whole blood fatty acid composition at birth : From the maternal compartment to the infant by C. Agostoni et al.
lable at ScienceDirect
Clinical Nutrition 30 (2011) 503e505Contents lists avaiClinical Nutrition
journal homepage: ht tp: / /www.elsevier .com/locate/c lnuOriginal Article
Whole blood fatty acid composition at birth: From the maternal compartment
to the infant
Carlo Agostoni a,*, Claudio Galli c, Enrica Riva b, Patrizia Risé c, Claudio Colombo c, Marcello Giovannini b,
Franca Marangoni c
aDepartment of Maternal and Pediatric Sciences, University of Milan, Fondazione IRCCS Cà Granda e Ospedale Maggiore Policlinico, Milan, Italy
bDepartment of Pediatrics, San Paolo Hospital, University of Milan, Milan, Italy
cDepartment of Pharmacological Sciences, University of Milan, Milan, Italya r t i c l e i n f o
Article history:
Received 13 August 2009
Accepted 31 January 2011
Keywords:
Fatty acids
Long-chain polyunsaturated fatty acids
Pregnancy
Cord blood
Newborn infants* Corresponding author. Tel.: þ39 02 55032452; fa
E-mail address: carlo.agostoni@unimi.it (C. Agosto
0261-5614/$ e see front matter  2011 Elsevier Ltd a
doi:10.1016/j.clnu.2011.01.016s u m m a r y
Background & aims: The biological role of fatty acids (FA) in the perinatal period is under active inves-
tigation. We here describe the application of a simpliﬁed microanalytical procedure to compare the FA
proﬁle of maternal, umbilical cord and infant whole blood, inclusive of all circulating lipid fractions and
cells.
Methods: The FA composition has been analyzed with a micromethod in 16 triplets, including maternal
blood, cord blood at delivery and infant blood at day 4, respectively.
Results: As expected, the FA composition of blood samples withdrawn from the umbilical cord is more
similar to the FA composition of blood from 4-day old infants than the FA pattern of maternal blood at
delivery. Nevertheless, infant blood FA proﬁle differed from cord for lower long-chain polyunsaturated FA
and higher monounsaturated FA.
Conclusions: Our explorative data using whole blood microanalysis conﬁrm the progressive increase of
long-chain polyunsaturated FA levels from the mothers towards cord and then infant blood.
 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.1. Introduction
The relevance of the essential polyunsaturated essential fatty
acids (PUFA), i.e. linoleic acid (LA, 18:2 n-6) and alpha linolenic
acid (ALA, 18:3 n-3), and of their long-chain polyunsaturated fatty
acid (LC-PUFA) derivatives for the structural and functional
development of brain cortex and retina has been supported by
a lot of data.1
The amounts of arachidonic (AA, 20:4 n-6) and docosahexaenoic
(DHA, 22:6 n-3) acids supplied to the foetus by the mother
throughout pregnancy are strictly dependent on maternal dietary
intakes andmetabolic processes taking place between thematernal
and infant compartments, respectively, at the placenta level.
Although the mechanisms at the cellular level are not fully eluci-
dated yet, the knowledge of the inter-relationships between these
compartments could be improved by the availability of analytical
methods for the assessment of the FA pattern in large population
groups. Finally, even if the composition of cord lipids has been
repeatedly analysed,2 few studies have explored the relationshipsx: þ39 02 50320226.
ni).
nd European Society for Clinical Nbetween maternal/cord FA and the FA composition of infant blood
lipid classes, for either ethical and practical reasons.
We here describe the application of a simpliﬁed microanalytical
procedure to compare the FA proﬁle of maternal, umbilical cord and
infant whole blood, as representative of all circulating lipid frac-
tions and cells.2. Methods
Sixteen healthy pregnant women aged 34 years (range 28e40),
who delivered healthy term infants (38.5 weeks, range 37.5e39.3),
with a weight appropriate for gestational age were recruited in our
maternity ward. Exclusion criteria included alcohol consumption
and smoking habits in order to avoid possible effects on the FA
status. All mothers signed written informed consent for the three
blood sampling procedures. The study had been previously
approved by the Local Committee on Ethics.
Cord venous blood drops were collected immediately after
infant delivery and after clamping of the cord. Maternal blood
drops were withdrawn through the puncture of a ﬁngertip, per-
formed with an automatic lancing device equipped with lancets.
Infant blood samples were collected from a heel prick at the same
time of the Guthrie neonatal screening test on day 4 of life. Allutrition and Metabolism. All rights reserved.
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formula.
All the samples were adsorbed on strips of chromatography
paper, following an innovative method validated for reproduc-
ibility3 and comparison with plasma and cell FA proﬁles,4 and
already applied to studies in adults5 and infants.6,7 All the samples
were directly subjected to transmethylation for gaschromato-
graphic analysis using DANI GC 1000 equipped with an Omegawax
TM320 capillary column (30 m, ID 0.32 mm, df 0.25 mm) and FID as
detector. FA were recognized by the use of reference standards and
values were expressed as FA weight percentages.
The SPSS package 16.0 forWindows (SPSS, Chicago, IL) was used
for the statistical analyses. Data (expressed as median, minimum
and maximum) were compared with non-parametric tests for
3 related samples (Friedman test) and post-hoc analysis with
Dunn’s test. Inter-relationships between FA were investigated with
the non-parametric Spearman’s r.3. Results
Infant characteristics at birth (median and range) were as
follows: weight 3.250 (2.760e4.010) gr, length 50 (47e54) cm and
head circumference 34 (33e36) cm. The FA composition of whole
blood in the three analysed compartments is reported in Table 1.
As expected, the FA composition of blood samples withdrawn
from the umbilical cord is more similar to the FA composition of
blood from 4-day old infants than the FA pattern of maternal blood
at delivery. Nevertheless, differences between infant and cord
blood FA composition are present, with lower LC-PUFA and higher
monounsaturated FA. Di-homo-gamma linolenic acid (DHGLA,
20:3 n-6), AA and DHA levels in blood from cord are higher, but in
the same order of magnitude than in infant’s samples, and are
around 2-folds higher than in maternal blood. Conversely, the
levels of LA and ALA are 3- to 4-folds lower in cord and infant blood,
compared to mothers.
Considering the main product/precursor ratios, representative
of the different metabolic steps involved in LC-PUFA biosynthesis of
the two metabolic series, regulated by desaturase and elongase
reactions, the ratios of the two main products (AA and DHA) with
their 18 carbon precursors (LA and ALA, respectively) are similar in
cord and infant blood. Nevertheless, considering the ratios of AATable 1
Percentage levels of the main individual FA, classes and product/precursor ratios (n ¼ 16
FA Maternal Cord
Median Min Max Median
18:0 7.47 6.40 10.4 16.9
18:1 n-9 24.1 18.4 29.6 13.0
18:2 n-6 20.4 15.4 29.7 5.61ns
20:3 n-6 1.36ns 1.08 2.33 2.51
20:4 n-6 6.36 3.64 8.16 14.6
18:3 n-3 0.20 0.15 0.71 0.08ns
20:5 n-3 0.15 0.07 0.29 0.08
22:6 n-3 1.70 0.69 2.68 3.88
Saturated 38.6 35.0 42.5 50.6ns
Monounsaturated 28.8 22.5 34.7 18.2
Polyunsaturated 32.3ns 26.0 42.0 31.0ns
Total n-6 29.1 23.6 38.3 26.6
Total n-3 2.36 1.29 3.75 4.37ns
DHGLA/LA 0.07 0.04 0.13 0.46
AA/DHGLA 4.54 2.79 6.17 5.89
AA/LA 0.29 0.18 0.42 2.61ns
EPA/ALA 0.61 0.29 1.13 1.04ns
DHA/ALA 7.86 2.86 12.0 45.0ns
DHA/EPA 12.4 4.93 0.13 41.6
Friedman test (3 related samples, non-parametric). ns indicates the absence of statisticaland DHA with the major intermediates (DHGLA and eicosa-
pentaeoic acid, EPA, 20:5 n-3, respectively), the AA/DHGLA ratio
(on the n-6 pathway) is higher in infant blood while the DHA/EPA
ratio (on the n-3 pathway) is higher in cord blood.
Mutual inter-relationships have been also investigated for LA,
ALA, AA, EPA and DHA values for maternal vs cord, maternal vs
neonatal, and cord vs neonatal values, respectively. As concerns
maternal vs cord values signiﬁcant relationships have been found
for LA (r¼ 0.575, P¼ 0.020) and EPA (r¼ 0.673, P¼ 0.004), while as
far as cord vs neonatal percentage concentrations, a signiﬁcant
correlation has been found only for LA (r ¼ 0.526, P ¼ 0.036). No
other relations between the levels of the same fatty acid and the
three compartments have been found.4. Discussion
To our knowledge, this is the ﬁrst study investigating the FA
composition of whole blood in triplets of mothers, cord and infants.
Other previous studies have considered the relationship between
the maternal compartments and the infants by analysing plasma
total lipids or phospholipids or red blood cells. However whole
blood lipids are representative of the FA composition of all the
circulating lipid classes, lipoproteins and cells. Our observations
conﬁrm previous observations with different methodology on the
progressively higher levels of LC-PUFA from mothers towards cord
and infants, respectively.8 In this context, the infant FA proﬁle only
marginally reﬂects the maternal FA status, partly depending on the
maternal release and partly upon themetabolism in the placenta or
the infant. The biomechanisms at the basis of these differences are
actually under active investigation. In spite of the documented LC-
PUFA biosynthesis in both preterm and term newborns,9 the two
major LC-PUFA (AA and DHA) inwhole blood are already decreased
at four days of life compared to cord levels Consumption and/or
utilization rates higher than synthetic capacities of infants might
explain these observations. Of interest, maternal n-3 LC-PUFA
levels (including both EPA and DHA) are related to the n-3 LC-PUFA
levels of cord but not of infants.
We conclude that, consistent with the explorative purposes of
our study, the micro invasive and microanalytical method for the
whole blood FA analysis seems to be a useful tool to obtain further
information concerning fatty acids from larger populations and; medians, min-max) in the different blood samples.
Infant
Min Max Median Min Max
15.5 18.0 15.0 12.4 16.4
11.7 15.3 16.9 13.6 21.7
4.14 7.17 4.88ns 3.08 9.16
1.73 3.19 1.50ns 1.32 2.03
12.9 15.9 13.1 9.81 16.0
0.04 0.33 0.08ns 0.03 0.21
0.03 0.14 0.10 0.05 0.23
1.90 4.93 3.28 1.63 3.95
46.8 52.9 51.1ns 47.5 54.4
16.7 21.9 22.7 18.6 28.0
26.5 33.3 26.4 21.5 30.0
22.8 28.4 22.2 18.3 25.6
2.39 5.48 3.74ns 2.13 4.46
0.29 0.72 0.28 0.18 0.66
4.38 7.67 8.53 5.81 10.7
1.90 3.74 2.72ns 1.17 4.10
0.30 2.28 1.44ns 0.53 2.39
10.9 89.7 47.3ns 11.7 114.8
28.0 133.3 32.5 10.6 66.8
ly signiﬁcant between-group differences at post-hoc analysis (Dunn’s test).
C. Agostoni et al. / Clinical Nutrition 30 (2011) 503e505 505elucidate the mechanisms regulating the transfer/distribution of
PUFA within the maternal-infant dyad.
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